Department of Cardiovascular Surgery, Sakakibara Heart Institute.
Circ J. 2013;77(9):2232-9. doi: 10.1253/circj.cj-13-0827. Epub 2013 Aug 3.
With the development of techniques and technologies in the past decade, minimally invasive valve surgery (MIVS) has become a well-established surgical option for heart valve disease. Unlike emerging transcatheter valves, MIVS still requires cardiopulmonary bypass and cardiotomy. The only difference between minimally invasive and conventional valve operations is whether a full sternotomy is avoided or not. The minimally invasive approach has been shown to have some beneficial effects such as reduced blood transfusion and faster postoperative recovery. However, these could be limited and outweighed by the potential adverse effects of small access. Careful selection of patient, approach and perfusion strategy based on thorough preoperative assessment and each surgical team experience is necessary to perform MIVS safely.
在过去十年中，技术和技术的发展使得微创瓣膜手术（MIVS）成为心脏瓣膜疾病的一种成熟的手术选择。与新兴的经导管瓣膜不同，MIVS 仍然需要体外循环和心脏切开术。微创和常规瓣膜手术的唯一区别在于是否避免了完全胸骨切开术。微创方法已显示出一些有益的效果，如减少输血和更快的术后恢复。然而，这些可能会受到小入路的潜在不利影响的限制和超过。根据彻底的术前评估和每个手术团队的经验，对患者、入路和灌注策略进行仔细选择，对于安全地进行 MIVS 是必要的。
